These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7467406)

  • 21. Metabolic disposition of 14C-labelled Brown HT in the rat, mouse and guinea-pig.
    Phillips JC; Mendis D; Gaunt IF
    Food Chem Toxicol; 1987 Dec; 25(12):1013-9. PubMed ID: 3692393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition and metabolism of [14C]sparfloxacin in the rat.
    Matsunaga Y; Miyazaki H; Oh-e Y; Nambu K; Furukawa H; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1991 Jul; 41(7):747-59. PubMed ID: 1663354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on the pharmacokinetics of BMY-28100 (I)].
    Nakanomyo H; Ishikawa K; Esumi Y; Takaichi M; Jin Y; Gunji S; Ishikawa H; Sonobe J
    Jpn J Antibiot; 1990 Jul; 43(7):1310-24. PubMed ID: 2232159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of 14C-loprazolam in animals and man.
    Illing HP; Ings RM; Johnson KI; Fromson JM
    Xenobiotica; 1983 Jul; 13(7):439-49. PubMed ID: 6140793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and disposition of phenazopyridine in rat.
    Thomas BH; Whitehouse LW; Solomonraj G; Paul CJ
    Xenobiotica; 1993 Feb; 23(2):99-105. PubMed ID: 8498084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disposition and metabolism of 14C-dehydrocorydaline in mice and rats].
    Fujii T; Miyazaki H; Nambu K; Kagemoto A; Hashimoto M
    Radioisotopes; 1984 Aug; 33(8):519-25. PubMed ID: 6505303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption, distribution and excretion of sultopride in man and several animal species.
    Kobari T; Iguro Y; Ito T; Namekawa H; Kato Y; Yamada S
    Xenobiotica; 1985 Jul; 15(7):605-13. PubMed ID: 4049901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplacental and mammary passage of radioactivity in rats treated vaginally and orally with [14C]propranolol.
    Buttar HS; Moffatt JH; Bura C
    J Toxicol Environ Health; 1988; 24(1):1-18. PubMed ID: 3373560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition in rats and mice of chloropractolol, a new beta-blocking agent.
    Godeneche D; Pilichowski JF; Meyniel G
    Xenobiotica; 1980 Sep; 10(9):725-33. PubMed ID: 6108651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
    John BA; Chasseaud LF; Wood SG; Forlot P
    Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
    Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The absence of cerebellar granule cell necrosis in the mouse following L-2-chloropropionic acid administration.
    Lock EA; Gyte A; Duffell S; Wyatt I
    Arch Toxicol; 2000 Nov; 74(9):547-54. PubMed ID: 11131035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria infection impairs glucuronidation and biliary excretion by the isolated perfused rat liver.
    Murdoch RT; Ghabrial H; Mihaly GW; Morgan DJ; Smallwood RA
    Xenobiotica; 1991 Dec; 21(12):1571-82. PubMed ID: 1785204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal handling of mercury in the rat: implications of intestinal secretion of inorganic mercury following biliary ligation or cannulation.
    Zalups RK
    J Toxicol Environ Health A; 1998 Apr; 53(8):615-36. PubMed ID: 9572160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.